1. OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY. (September 2021) Authors: Ferretti, F.; Cannatelli, R.; Monico, M.C.; Carvalhas Gabrielli, A.M.; Carmagnola, S.; Maconi, G.; Ardizzone, S. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.09.7 THE IMPACT OF BIOLOGIC THERAPIES ON EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE OBSERVATIONAL STUDY. (September 2021) Authors: Ferretti, F.; Monico, M.C.; Cannatelli, R.; Carmagnola, S.; Maconi, G.; Ardizzone, S. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗